Embolic Protection Devices Market Emerging Opportunities in Upcoming Years by Leading Key Players F. Hoffman-La Roche Ltd, Abbott Laboratories, Danaher, Thermo Fischer Scientific Inc., Siemens Medical Solutions USA, Inc., Abaxis, Hologenic Inc., Bio-Rad L
“Global Embolic Protection Devices Market– Industry Trends and Forecast to 2025” newly adds in Data Bridge Market Research database. This report covers leading key company profiles with information such as business overview, regional analysis, consumption
(EMAILWIRE.COM, May 03, 2018 ) The Global Embolic Protection Devices Market is expected to reach USD 698.6 Million by 2025, from USD 374.65 Million in 2017 growing at a CAGR of 8.1% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2017, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Some of the major players operating in the global embolic protection devices market are F. Hoffman-La Roche Ltd, Abbott Laboratories, Danaher, Thermo Fischer Scientific Inc., Siemens Medical Solutions USA, Inc., Abaxis, Hologenic Inc., Bio-Rad Laboratories Inc., Becton, Dickenson and Company (BD), Alere and Enzo Biochem Inc, Trivitron Healthcare, Snibe Diagnostics, Sinduri Biotec, Sekisui Medical, Nipro Diagnostics, Mindray, nstrumentation Laboratory among others.
Get Free Sample copy of report at http://databridgemarketresearch.com/request-a-sample/?dbmr=global-embolic-protection-devices-market
Embolic protection devices are used during the percutaneous cardiac procedures that help in reducing the complications arising due to plaques debris in blood vessels. Embolic protection is used in case of cerebral, cardiovascular. Embolic protection devices are classified into proximal occlusion device, distal occlusion devices and filters. Proximal occlusion devices are most upgraded devices and they avoid the plaque disruption. Example Mo.Ma Ultra (Medtronic) Distal occlusion device prevents embolization via balloon occlusion. According to American Heart Association, cardiovascular diseases are major cause of death across world, claiming more than 17 million deaths in 2013. In February 2018, Claret medical announced the adoption of sentinel cerebral protection system by 50 U.S centers, which in turn leading to increase market value of Claret medical. In June 2017, Claret Medical received the U.S FDA approval in the U.S for sentinel cerebral protection system for reducing the risk of stroke. This device captures the and removes the plaques debris during transcatheter aortic valve replacement (TAVR) in the U.S. Sentinel is the first and only FDA Approved embolic protection device used for cerebral blockages.
Access More Details at http://databridgemarketresearch.com/reports/global-embolic-protection-devices-market/
The global embolic protection devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market. The report includes market shares of embolic protection devices market for global, Europe, North America, Asia Pacific and South America.
Major Market Drivers and Restraints:
- Increased in incidence of cardiovascular and neurological diseases,
- Increase in the funds for the research and development in embolic protection devices.
- Increase in demand for minimally invasive procedures.
- Unfavorable government policies and regulatory scenario
- Increase in transcatheter aortic valve replacement.
- Downward pricing pressure owing to its commodity nature
Inquire before buying at http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-embolic-protection-devices-market
Note: If you have any special requirements, please let us know and we will offer you the report as you want.
Some of the major players operating in the global embolic protection devices market are F. Hoffman-La Roche Ltd, Abbott Laboratories, Danaher, Thermo Fischer Scientific Inc., Siemens Medical Solutions USA, Inc., Abaxis, Hologenic Inc., Bio-Rad Laboratories Inc., Becton, Dickenson and Company (BD), Alere and Enzo Biochem Inc, Trivitron Healthcare, Snibe Diagnostics, Sinduri Biotec, Sekisui Medical, Nipro Diagnostics, Mindray, nstrumentation Laboratory among others.
Get Free Sample copy of report at http://databridgemarketresearch.com/request-a-sample/?dbmr=global-embolic-protection-devices-market
Embolic protection devices are used during the percutaneous cardiac procedures that help in reducing the complications arising due to plaques debris in blood vessels. Embolic protection is used in case of cerebral, cardiovascular. Embolic protection devices are classified into proximal occlusion device, distal occlusion devices and filters. Proximal occlusion devices are most upgraded devices and they avoid the plaque disruption. Example Mo.Ma Ultra (Medtronic) Distal occlusion device prevents embolization via balloon occlusion. According to American Heart Association, cardiovascular diseases are major cause of death across world, claiming more than 17 million deaths in 2013. In February 2018, Claret medical announced the adoption of sentinel cerebral protection system by 50 U.S centers, which in turn leading to increase market value of Claret medical. In June 2017, Claret Medical received the U.S FDA approval in the U.S for sentinel cerebral protection system for reducing the risk of stroke. This device captures the and removes the plaques debris during transcatheter aortic valve replacement (TAVR) in the U.S. Sentinel is the first and only FDA Approved embolic protection device used for cerebral blockages.
Access More Details at http://databridgemarketresearch.com/reports/global-embolic-protection-devices-market/
The global embolic protection devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market. The report includes market shares of embolic protection devices market for global, Europe, North America, Asia Pacific and South America.
Major Market Drivers and Restraints:
- Increased in incidence of cardiovascular and neurological diseases,
- Increase in the funds for the research and development in embolic protection devices.
- Increase in demand for minimally invasive procedures.
- Unfavorable government policies and regulatory scenario
- Increase in transcatheter aortic valve replacement.
- Downward pricing pressure owing to its commodity nature
Inquire before buying at http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-embolic-protection-devices-market
Note: If you have any special requirements, please let us know and we will offer you the report as you want.
Contact Information:
Data Bridge Market Research
Data Bridge Market Resea
Tel: +1-888-387-2818
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Data Bridge Market Research
Data Bridge Market Resea
Tel: +1-888-387-2818
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results